Bayer AG - The seed is growing

Last year went well for Bayer AG, with a consolidated net income of EUR 1 billion. In 2020, Bayer had posted a loss of EUR 10.5 billion. This was largely due to the formation of reserves for the Monsanto litigation. The Group also has to forfeit the loss of exclusivity rights to two of its most profitable pharmaceutical products. However, the seed business is picking up, as is the demand for pesticides. Thanks to its CropScience, Pharmaceuticals and Consumer Health divisions, Bayer has three mainstays. Back in the black, the Leverkusen-based company faces its next challenge: potential crisis effects from the Ukraine war and its consequences on the global economy have not yet been priced in.

Den vollständigen Artikel lesen ...